UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Comparisons of two iteration methods for time-harmonic parabolic optimal control problems

Computers & mathematics with applications (1987), 2024-04, Vol.159, p.44-59

2024

Volltextzugriff (PDF)

Artificial intelligence using deep neural network learning for automatic location of the interscalene brachial plexus in ultrasound images

European journal of anaesthesiology, 2022-09, Vol.39 (9), p.758-765

2022

Volltextzugriff (PDF)

Skin reactions caused by bone-anchored hearing aid(BAHA) implantation

Journal of otology (Beijing), 2015-12, Vol.10 (4), p.159-162

2015

Volltextzugriff (PDF)

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Nature communications, 2020-11, Vol.11 (1), p.5679-5679, Article 5679

2020

Volltextzugriff (PDF)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Breast cancer research : BCR, 2016-03, Vol.18 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Clinical cancer research, 2022-07, Vol.28 (13), p.2807-2817

2022

Volltextzugriff (PDF)

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Oncogene, 2021-03, Vol.40 (12), p.2323-2334

2021

Volltextzugriff (PDF)

LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

Molecular cancer, 2020-05, Vol.19 (1), p.87-87, Article 87

2020

Volltextzugriff (PDF)

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Cancer, 2019-07, Vol.125 (13), p.2185-2193

2019

Volltextzugriff (PDF)

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5491-5505

2021

Volltextzugriff (PDF)

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

The lancet oncology, 2024-02, Vol.25 (2), p.184-197

2024

Volltextzugriff (PDF)

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer

Cell research, 2024-01, Vol.34 (1), p.58-75

2024

Volltextzugriff (PDF)

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.837-848

2012

Volltextzugriff (PDF)

Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression

Proceedings of the National Academy of Sciences - PNAS, 2022-11, Vol.119 (46), p.e2207201119

2022

Volltextzugriff (PDF)

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Breast cancer research and treatment, 2021, Vol.185 (2), p.371-380

2021

Volltextzugriff (PDF)

Effect of balloon dilation eustachian tuboplasty combined with tympanic tube insertion in the treatment of chronic recurrent secretory otitis media

European archives of oto-rhino-laryngology, 2019-10, Vol.276 (10), p.2715-2720

2019

Volltextzugriff (PDF)

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Science advances, 2019-03, Vol.5 (3), p.eaat9820-eaat9820

2019

Volltextzugriff (PDF)

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359231225032-17588359231225032

2024

Volltextzugriff (PDF)

Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?

Breast cancer research and treatment, 2022-11, Vol.196 (1), p.97-109

2022

Volltextzugriff (PDF)

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Breast cancer research : BCR, 2007-01, Vol.9 (6), p.R76-R76, Article R76

2007

Volltextzugriff (PDF)

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Proteomics (Weinheim), 2006-06, Vol.6 (11), p.3352-3368

2006

Volltextzugriff (PDF)

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

Cell discovery, 2023-12, Vol.9 (1), p.125-125, Article 125

2023

Volltextzugriff (PDF)

Etiology of newborn hearing impairment in Guangdong province: 10-year experience with screening, diagnosis, and follow-up

World journal of pediatrics : WJP, 2020-06, Vol.16 (3), p.305-313

2020

Volltextzugriff (PDF)

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy

PloS one, 2014-12, Vol.9 (12), p.e114646-e114646

2014

Volltextzugriff (PDF)

Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China

BMC cancer, 2015-03, Vol.15 (1), p.201-201, Article 201

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(82)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparisons of two iteration methods for time-harmonic parabolic optimal control problems

Artificial intelligence using deep neural network learning for automatic location of the interscalene brachial plexus in ultrasound images

Skin reactions caused by bone-anchored hearing aid(BAHA) implantation

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Effect of balloon dilation eustachian tuboplasty combined with tympanic tube insertion in the treatment of chronic recurrent secretory otitis media

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

Etiology of newborn hearing impairment in Guangdong province: 10-year experience with screening, diagnosis, and follow-up

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy

Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China

Suchergebnisse filtern